Dr Holly Elsbeth Dunn, MD | |
1933 Pine Ste, Ste A, Abilene, TX 79601 | |
(325) 692-0626 | |
(325) 692-0638 |
Full Name | Dr Holly Elsbeth Dunn |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 14 Years |
Location | 1933 Pine Ste, Abilene, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275851198 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | Q1816 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cook Childrens Physician Network | 7719884584 | 164 |
News Archive
Australia's Liberal opposition has allowed the Rudd government to implement the paid parental leave scheme with effect from 1st January 2011. As per this scheme both parents will get an 18 weeks' paid leave at the minimum wage rate of $543 a week. At present Australia is one of the only two OECD countries that does not have a paid parental scheme.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Amid the debate about reforming heath care in the United States, it's tough to turn on your television these days without hearing a political ad condemning the Canadian health care system.
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Power3 Medical Products, Inc. announced that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer's disease.
› Verified 6 days ago
Entity Name | Utmb Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
Australia's Liberal opposition has allowed the Rudd government to implement the paid parental leave scheme with effect from 1st January 2011. As per this scheme both parents will get an 18 weeks' paid leave at the minimum wage rate of $543 a week. At present Australia is one of the only two OECD countries that does not have a paid parental scheme.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Amid the debate about reforming heath care in the United States, it's tough to turn on your television these days without hearing a political ad condemning the Canadian health care system.
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Power3 Medical Products, Inc. announced that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer's disease.
› Verified 6 days ago
Entity Name | Cook Childrens Physician Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750369203 PECOS PAC ID: 7719884584 Enrollment ID: O20040128000800 |
News Archive
Australia's Liberal opposition has allowed the Rudd government to implement the paid parental leave scheme with effect from 1st January 2011. As per this scheme both parents will get an 18 weeks' paid leave at the minimum wage rate of $543 a week. At present Australia is one of the only two OECD countries that does not have a paid parental scheme.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Amid the debate about reforming heath care in the United States, it's tough to turn on your television these days without hearing a political ad condemning the Canadian health care system.
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Power3 Medical Products, Inc. announced that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer's disease.
› Verified 6 days ago
Entity Name | Fetal Care Consultants, Llc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578883187 PECOS PAC ID: 0749466175 Enrollment ID: O20110518000787 |
News Archive
Australia's Liberal opposition has allowed the Rudd government to implement the paid parental leave scheme with effect from 1st January 2011. As per this scheme both parents will get an 18 weeks' paid leave at the minimum wage rate of $543 a week. At present Australia is one of the only two OECD countries that does not have a paid parental scheme.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Amid the debate about reforming heath care in the United States, it's tough to turn on your television these days without hearing a political ad condemning the Canadian health care system.
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Power3 Medical Products, Inc. announced that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer's disease.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Holly Elsbeth Dunn, MD Po Box 733784, Dallas, TX 75373-3784 Ph: (682) 885-1860 | Dr Holly Elsbeth Dunn, MD 1933 Pine Ste, Ste A, Abilene, TX 79601 Ph: (325) 692-0626 |
News Archive
Australia's Liberal opposition has allowed the Rudd government to implement the paid parental leave scheme with effect from 1st January 2011. As per this scheme both parents will get an 18 weeks' paid leave at the minimum wage rate of $543 a week. At present Australia is one of the only two OECD countries that does not have a paid parental scheme.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Amid the debate about reforming heath care in the United States, it's tough to turn on your television these days without hearing a political ad condemning the Canadian health care system.
The Hill reports that as Republicans call for repeal of the law, the Obama administration is quick to push back. Writing Thursday on the White House blog, Stephanie Cutter, the president's communications guru, noted that repealing the reforms would eliminate all the patient protections that just took effect.
Power3 Medical Products, Inc. announced that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer's disease.
› Verified 6 days ago
Nicole C Bullock, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6250 Regional Plz, Suite 1010, Abilene, TX 79606 Phone: 325-428-5500 Fax: 325-428-5519 | |
Dr. Stuart Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St, Suite 402, Abilene, TX 79601 Phone: 325-670-6860 Fax: 325-670-6861 | |
Dr. Jessica Ann Ortolano, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1850 Hickory St, Suite 200d, Abilene, TX 79601 Phone: 325-670-5385 Fax: 325-670-5389 | |
Jerry Sinclair, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1680 Antilley Rd, #380, Abilene, TX 79606 Phone: 325-691-1122 | |
Dr. Timothy Joseph Hill Ii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St Ste 401b, Abilene, TX 79601 Phone: 325-670-4242 Fax: 833-437-1269 | |
Stefanie Bertie Mccain, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19 Hospital Dr, Abilene, TX 79606 Phone: 325-690-0620 Fax: 325-690-0622 | |
Dr. Katherine Hall Jelliffe, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1933 Pine St Ste A, Abilene, TX 79601 Phone: 325-692-0626 Fax: 325-692-0638 |